Getinge AB (publ) (OTCMKTS:GNGBY) Given Consensus Rating of “Hold” by Brokerages

Getinge AB (publ) (OTCMKTS:GNGBY – Get Rating) has been assigned a consensus rating of “Hold” from the eight ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $280.00.

GNGBY has been the topic of a number of research analyst reports. Nordea Equity Research raised shares of Getinge AB (publ) from a “hold” rating to a “buy” rating in a report on Thursday, October 20th. DNB Markets cut shares of Getinge AB (publ) from a “buy” rating to a “hold” rating in a report on Friday, December 30th. JPMorgan Chase & Co. cut shares of Getinge AB (publ) from a “neutral” rating to an “underweight” rating in a report on Tuesday, January 3rd. Finally, Morgan Stanley initiated coverage on shares of Getinge AB (publ) in a report on Tuesday, October 18th. They issued an “overweight” rating on the stock.

Getinge AB (publ) Stock Up 1.0 %

Shares of Getinge AB (publ) stock opened at $21.59 on Friday. Getinge AB has a 52-week low of $15.87 and a 52-week high of $41.54. The company has a 50 day moving average of $21.82 and a 200 day moving average of $20.62. The company has a market capitalization of $5.88 billion, a P/E ratio of 20.96 and a beta of 1.22.

Getinge AB (publ) (OTCMKTS:GNGBY – Get Rating) last released its quarterly earnings data on Wednesday, October 19th. The company reported $0.29 earnings per share for the quarter. Getinge AB (publ) had a net margin of 9.70% and a return on equity of 12.01%. The company had revenue of $658.92 million for the quarter.

Getinge AB (publ) Company Profile

(Get Rating)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products.